The Impact of Article 39.3 in India: A Practical Perspective
India is currently debating whether to provide exclusivity for pharmaceutical test data. The various Ministries in the Government are planned to meet on 12 July 2006. I-MAK has produced a documet which reviews the practical impact of the current proposals and provides recommendations which should be considered before a final decision is reached.
The Initiative for Medicines, Access &Knowledge (I-MAK) is an initiative to bring new and practical perspectives to issues impacting medicines, access and knowledge